Log in

Loncar China BioPharma ETF Stock Forecast, Price & News

+0.03 (+0.10 %)
(As of 10/22/2020 12:00 AM ET)
Today's Range
Now: $30.74
50-Day Range
MA: $30.70
52-Week Range
Now: $30.74
Volume938 shs
Average Volume5,182 shs
Market Capitalization$11.53 million
P/E RatioN/A
Dividend Yield0.13%

Geographic Exposure of CHNA

Currency Exposure of CHNA

Sector Exposure of CHNA

Industry Exposure of CHNA

Basic Details

Issuer Exchange Traded Concepts
Fund NameLoncar China Biopharma ETF
Tax ClassificationRegulated Investment Company
Inception Date8/14/2018
Fund ManagerDenise M. Krisko, Habib Moudachirou

Fund Focus

Asset ClassEquity
BenchmarkLoncar China BioPharma Index
FocusHealth Care
Development LevelEmerging Markets

Fund Statistics

Assets Under Management$10.00 million
Average Daily Volume$7,640.20

ETF Expenses

Management Fee0.79%
Other Expenses0.00%
Total Expenses0.79%
Fee Waiver0.00%
Net Expenses0.79%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorExchange Traded Concepts, LLC
CustodianU.S. Bank National Association
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bancorp Fund Services, LLC
Lead Market Maker
+0.03 (+0.10 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHNA News and Ratings via Email

Sign-up to receive the latest news and ratings for CHNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Loncar China BioPharma ETF (NASDAQ:CHNA) Frequently Asked Questions

How has Loncar China BioPharma ETF's stock price been impacted by COVID-19 (Coronavirus)?

Loncar China BioPharma ETF's stock was trading at $24.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CHNA stock has increased by 26.5% and is now trading at $30.7442.
View which stocks have been most impacted by COVID-19

Are investors shorting Loncar China BioPharma ETF?

Loncar China BioPharma ETF saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 500 shares, an increase of 150.0% from the August 31st total of 200 shares. Based on an average daily trading volume, of 4,900 shares, the short-interest ratio is presently 0.1 days.
View Loncar China BioPharma ETF's Short Interest

What other stocks do shareholders of Loncar China BioPharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China BioPharma ETF investors own include Baidu (BIDU), salesforce.com (CRM), Canopy Growth (CGC), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Aphria (APHA), Advanced Micro Devices (AMD) and Analog Devices (ADI).

What is Loncar China BioPharma ETF's stock symbol?

Loncar China BioPharma ETF trades on the NASDAQ under the ticker symbol "CHNA."

How do I buy shares of Loncar China BioPharma ETF?

Shares of CHNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Loncar China BioPharma ETF's stock price today?

One share of CHNA stock can currently be purchased for approximately $30.74.

How big of a company is Loncar China BioPharma ETF?

Loncar China BioPharma ETF has a market capitalization of $11.53 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.